Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Sweet Peaches wants a bigger piece of the pie; crowdfunding could scale this small biz across US
Community support will be key for Sweet Peaches Cobblers next batch of growth, said Denisha Jones, announcing plans to use Kickstarter funding to pack her flavorful and beloved family desserts into the freezers of more major retailers across the U.S. Already a local Kansas City favorite, Sweet Peaches Cobbler can be found in more than…
Jeremy Terman turned a likely ‘no’ into a tech career; his advice: Don’t wait for permission to start
The biggest risks are in doing nothing, said Jeremy Terman, encouraging entrepreneurship students at UMKC to take the plunge — even if at times the world might be telling them they aren’t ready. “You don’t have to be in a box. You don’t have to listen to what the rules are,” said Terman, an investor…
Cybersecurity automation: How to do more with less
Editor’s note: The opinions expressed in this commentary are the author’s alone. BARR Advisory, which has offices in Kansas City, is a cloud-based security and compliance solutions provider, specializing in cybersecurity, is a financial partner of Startland News. Click here to check out more from this Cybersecurity Month series from BARR Advisory. In today’s rapidly…
ARtechBBQ is back, bringing Oktoberfest vibes to KC’s best-smelling celebration of tech
While the party has grown larger each year, Greg Kratofil said, the goal of the ARtechBBQ remains the same: to highlight Kansas City’s tech community at what he calls the closest thing the city has to Mardi Gras. The hotly-anticipated, one-night-only event returns 6 p.m. to midnight Nov. 1 at the Kansas Speedway during the…